Higher Law: FDA Routes ‘New Regulatory Pathway for CBD’ Through Congress

Welcome back to Higher Law, our weekly briefing on all things cannabis. I’m Cheryl Miller, reporting for Law.com from Sacramento. 

This week we’re looking at:

• The FDA’s punt to Congress on CBD rules.
• Marijuana, marionberries and the Dormant Commerce Clause.
• A lawyer elected director of the Minority Cannabis Business Association.
• AI and cannabis law.